Please provide your email address to receive an email when new articles are posted on . A novel encapsulated cell therapy shows efficacy in the treatment of macular telangiectasia. This could provide ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) ...

SAN FRANCISCO--(BUSINESS WIRE)--Encellin, a biotechnology company developing a cell encapsulation platform with an initial focus on Type 1 Diabetes (T1D), announced the closing of a $9.9M financing ...

An implantable device contains encapsulated cells that produce insulin, plus a tiny oxygen-producing factory that keeps them healthy. MIT engineers have come one step closer to the goal of treating ...

A Finnish team used a one-step method for polydimethylsiloxane encapsulated perovskite solar cells that simultaneously provide anti-reflective light management and shielding from oxygen and ...

Please provide your email address to receive an email when new articles are posted on . Two studies demonstrated statistical and clinical efficacy for the treatment of MacTel over 2 years, “but we ...

A pair of phase 3 trials of Neurotech Pharmaceuticals’ encapsulated cell therapy implant have met their primary endpoints, positioning the biotech to talk to the FDA about bringing the treatment for a ...

Vertex Pharmaceuticals VRTX announced the clearance of an Investigational New Drug (IND) application by the FDA for VX-264, its novel encapsulated cell therapy candidate for the potential treatment of ...

Just as insulin therapy revolutionized life for people with type I diabetes (TID) a century ago, a new implant may one day do the same by tackling the disease’s biggest challenge—keeping transplanted ...

Chinese researchers have demonstrated organic solar cells with novel encapsulation and a protective interfacial layer for enhanced stability and efficiency. The best performing cell based on the new ...